Evolving Strategies to Attack Hepatitis C
New treatment combinations are highly toxic but have substantial success rates
by Michael Norton, P.A.
Hepatitis C Drug Controversy
Schering-Plough packages its HCV drugs together at a heavy price
Drug Pricing: Soaring Prices, Soaring Sales
This fall brought some modest community victories despite generally increasing prices
By Linda Grinberg
Federal Budget: Wrapping Up the 105th Congress
The new budget contains large increases for HIV research and care
By Derek Link
|
Treatment Issues
Editor: Dave Gilden Medical Consultant: Gabriel Torres, M.D. Art Director: Adam Zachary Fredericks Technical & Marketing Coordinator: Fred Gormley Proofreaders: Doug Goertzen, Ellie Tweedy, Carol Vizzier Volunteer Support Staff: Edward Friedel, Helen Kane, Allan Post, Lenore Rey, Eva Zysman Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues |